Sweet targets: sugar nucleotide biosynthesis inhibitors

Future Med Chem. 2022 Mar;14(5):295-298. doi: 10.4155/fmc-2021-0286. Epub 2022 Jan 7.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspergillus / enzymology
  • Bacterial Proteins / antagonists & inhibitors
  • Bacterial Proteins / metabolism
  • Carbohydrate Dehydrogenases / antagonists & inhibitors
  • Carbohydrate Dehydrogenases / metabolism
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / metabolism
  • Fungal Proteins / antagonists & inhibitors
  • Fungal Proteins / metabolism
  • Galactose / analogs & derivatives
  • Galactose / biosynthesis
  • Intramolecular Transferases / antagonists & inhibitors
  • Intramolecular Transferases / metabolism
  • Nucleoside Diphosphate Sugars / biosynthesis
  • Nucleotides / biosynthesis*
  • Nucleotidyltransferases / antagonists & inhibitors
  • Nucleotidyltransferases / metabolism
  • Pseudomonas aeruginosa / enzymology
  • Uridine Diphosphate / analogs & derivatives
  • Uridine Diphosphate / biosynthesis

Substances

  • Bacterial Proteins
  • Enzyme Inhibitors
  • Fungal Proteins
  • Nucleoside Diphosphate Sugars
  • Nucleotides
  • uridine diphosphate galactofuranose
  • GDP mannuronic acid
  • Uridine Diphosphate
  • Carbohydrate Dehydrogenases
  • GDPmannose dehydrogenase
  • Nucleotidyltransferases
  • UDPacetylglucosamine pyrophosphorylase
  • Intramolecular Transferases
  • UDP-galactopyranose mutase
  • Galactose